Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2015

Feb 6, 2015

30071_dirs_2015-02-06_185cde94-173d-4983-86bc-e089dc824727.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-02-04

Reporting Person: ROBERTS CHRISTOPHER G (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-04 ResMed Common Stock M 7500 $16.498 Acquired 111930 Direct
2015-02-04 ResMed Common Stock M 36000 $23.875 Acquired 147930 Direct
2015-02-04 ResMed Common Stock M 36000 $15.52 Acquired 183930 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-02-04 ResMed Common Stock Options $15.52 M 36000 Disposed 2015-11-20 ResMed Commmon Stock (36000) Direct
2015-02-04 ResMed Common Stock Options $16.498 M 7500 Disposed 2015-07-01 ResMed Commmon Stock (7500) Direct
2015-02-04 ResMed Common Stock Options $23.875 M 36000 Disposed 2016-07-07 ResMed Commmon Stock (36000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
ResMed Common Stock 269400 Indirect
ResMed Common Stock 136000 Indirect
ResMed Common Stock 23200 Indirect

Footnotes

F1: Represents date options became fully exercisable. These options vested 1/12 per month.

F2: Represents date options first became exercisable. These ptions vest 1/3 per year on the anniversary of the grant.